Table:
begin	end	state
1	6	non-cytoplasmic
7	36	transmembrane
37	42	cytoplasmic
43	68	transmembrane
69	76	non-cytoplasmic
77	96	transmembrane
97	109	cytoplasmic
110	135	transmembrane
136	145	non-cytoplasmic
146	163	transmembrane
164	169	cytoplasmic
170	189	transmembrane
190	199	non-cytoplasmic
200	224	transmembrane
225	246	cytoplasmic
247	276	transmembrane
277	315	non-cytoplasmic
316	339	transmembrane
340	351	cytoplasmic
352	373	transmembrane
374	384	non-cytoplasmic
385	404	transmembrane
405	410	cytoplasmic
411	441	transmembrane
442	463	non-cytoplasmic
464	484	transmembrane
485	498	cytoplasmic

Input:
>WP_040187856.1 NCBI__GCF_000821105.2:WP_040187856.1
MDILNHILSALPLIFSIDVIIAMIIGTAVGITVGALPGLSATMGIAVLIPLTFSMEPLVA
LGMVAGIYNGAMYGGSIPAILLRIPGTPAGIATVFDGYPMAQKGQAPLALKISLISSAIG
SAVSAIALLALAPPLAAIALKFSPADYFWLALFGMTTIAVLLSSNPVKGLLSTCLGLVVG
IVGIDAMTGAERFAFGSMDLLSGINIIVLLTGLFAIPPAIDLAVQHLSQQKEAPIENKKA
RIRWRPFIPVLIKSSIMGVVIGIIPALGGNIAAVLAWNEQRRSDPDNDQYGKGEPKGVAA
PECANNADTAATLIPALTLGIPGSAVAAVILGALLVHGLRPGPQLFRDDPEIVFGFMLTM
FVTAILMFVIGRVGARAFVHVLKAPTMLLAPMIIALAVVGIYSIHNSMFEVWLMLFFGLL
GYGMERLNIPTAPAVLAVILGPMAEESLRRALLISGGSFDYLVQSWISWIIIAMTAMTLI
VPMWKRFRRLKPSRGDQE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server